|
Dec 6
|
His dad worked on the factory floor at Johnson & Johnson. Now he’s the CFO
|
|
Dec 6
|
5 takeaways from J&J’s investor day
|
|
Dec 6
|
The Zacks Analyst Blog Highlights Johnson & Johnson, T-Mobile US, Caterpillar, Broadcom and Starbucks
|
|
Dec 6
|
Pharma Stocks With Nice Dividends: The RX Investors Need
|
|
Dec 6
|
J&J hernia mesh settlement prompts judge to dismiss more than 200 cases
|
|
Dec 5
|
J&J says it has settled some talc claims, will continue bankruptcy strategy
|
|
Dec 5
|
Johnson & Johnson (JNJ) Sees a More Significant Dip Than Broader Market: Some Facts to Know
|
|
Dec 5
|
Top Analyst Reports for Johnson & Johnson, T-Mobile & Caterpillar
|
|
Dec 5
|
UPDATE 1-Johnson & Johnson forecasts as much as 6% sales growth in 2024
|
|
Dec 5
|
Johnson & Johnson Stock Edges Higher After Guidance Release
|
|
Dec 5
|
Johnson & Johnson Targets Sales Growth in Years Ahead
|
|
Dec 5
|
J&J's (JNJ) Bladder Cancer Drug Gets FDA's Breakthrough Tag
|
|
Dec 5
|
Midday movers: CVS Health, Apple, and more
|
|
Dec 5
|
Johnson & Johnson forecasts as much as 6% sales growth in 2024
|
|
Dec 5
|
Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review
|
|
Dec 5
|
J&J pitches investors on sales growth from cancer, immune disease drugs
|
|
Dec 4
|
The past one-year earnings decline for Johnson & Johnson (NYSE:JNJ) likely explains shareholders long-term losses
|
|
Dec 4
|
The Executives Who Could Be Johnson & Johnson’s Next CEO
|
|
Dec 3
|
Second-Largest U.S. Pension Sold AMC, NIO, Spotify, and JNJ Stock
|
|
Dec 3
|
Warren Buffett sold a whopping $7B worth of stock in Q3 — and even unloaded 2 giant American 'dividend kings.' But here's why the Oracle of Omaha could be dead wrong
|